Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule; Transfer of Listing

As previously disclosed by Cachet Financial Solutions, Inc. (the “Company”) on a Current Report on Form 8-K, filed on March 22, 2017, Liyuan Woo, the chairperson of the Audit Committee and a member of the Corporate Governance Committee, resigned from the Company’s Board of Directors as a result of a conflict of interest between her new employer and not due to any disagreement with the Company or any of its directors or executive officers. On March 30, 2017, the Company received a Cure Letter from Nasdaq which notified the Company that the resignation of Ms. Woo caused the Company to no longer be compliant with Nasdaq’s independent director audit committee requirements as set forth in Listing Rule 5605. Pursuant to Listing Rule 5605, the Company intends to appoint a new director to comply with the independent director audit committee requirements within the cure period set forth in Listing Rules 5605(b)(1)(A) and 5605(c)(4), which is the earlier of the Company’s next annual shareholders’ meeting or March 22, 2018; or if the next annual shareholders’ meeting is held before September 18, 2017, then no later than September 18, 2017.